Metronidazole market to reach $0.8 billion by 2030 at 5.5% CAGR, driven by increasing incidence of bacterial infections.
Read More
Methylsulfonylmethane (msm) supplements market to reach $2.07 billion by 2030 at 8.9% CAGR, driven by increase in prevalence of joint disorders and rise in aging population.
Read More
Nephrology drugs market to reach $24.32 billion by 2030 at 6.7% cagr, driven by rising prevalence of chronic kidney disease.
Read More
Neck pain treatment solutions market to reach $8.79 billion by 2030 at 6.0% cagr, driven by increasing sedentary lifestyles.
Read More
Nebivolol tablets market to reach $1.67 billion by 2030 at 6.5% cagr, driven by increasing prevalence of cardiovascular diseases and growing demand for generic drugs.
Read More
Methicillin-resistant staphylococcus aureus (mrsa) drugs market to reach $3.25 billion by 2030 at 6.0% CAGR, driven by rising hospital acquired infections.
Read More
Methenamine hippurate tablets market to reach $14.49 billion by 2030 at 7.5% CAGR, driven by rising cases of urinary tract infections and rising healthcare expenditure.
Read More
The global nausea medicine market to reach $4.5 billion by 2030 at 6.9% cagr, driven by rising consumption of unhealthy diets.
Read More
Natural killer cell therapeutics market to reach $6.9 billion by 2030 at 11.9% cagr, driven by rising prevalence of cancer and demand for advanced immunotherapies.
Read More
Metastatic cancer drugs market to reach $79.32 billion by 2030 at 5.8% CAGR, driven by evolution of precision medicine and personalized therapies.
Read More